Probeer een andere zoekopdracht
Naam | Leeftijd | Sinds | Titel |
---|---|---|---|
Hiroshi Nomura | 65 | 2012 | CEO, President & Representative Director |
Mayumi Mochizuki | - | 2021 | Outside Audit & Supervisory Board Member |
Daishiro Michimori | - | 2022 | Outside Audit & Supervisory Board Member |
Takashi Kutsunai | 65 | 2014 | Full-Time Audit & Supervisory Board Member |
Hiroyuki Baba | 64 | 2014 | Mngg Exec. Officer of Global Data Design, Lgl Affairs. IP, IT Mgt, & Frontier Bus. Off. & Director |
Yoshiharu Ikeda | 65 | 2020 | Managing Executive Officer of Drug Research Division, Head of Japan Business Unit & Director |
Nobuhiro Endo | 70 | 2019 | Independent Outside Director |
Toru Kimura | 63 | 2016 | Sr. Mngg Exec. Off. of Glo. Crprate Stgy, F&A, Regen & Cell Med. Off., Kobe Ctr, Mfg. Plt and Dir. |
Shigeyuki Nishinaka | 59 | 2014 | Managing Executive Officer of Business Development & Management and Director |
Minoru Usui | 68 | 2021 | Independent Outside Director |
Koji Fujimoto | 60 | 2022 | Independent Outside Director |
Yoshio Iteya | 67 | 2018 | Outside Audit & Supervisory Board Member |
Hisayoshi Kashima | - | 2014 | Full-Time Audit & Supervisory Board Member |
Weet u zeker dat u %USER_NAME% wilt blokkeren?
Als u dit doet, kunnen u en %USER_NAME% geen publicaties meer van elkaar zien op Investing.com.
%USER_NAME% is toegevoegd aan uw lijst met geblokkeerde personen
Omdat u de blokkering van deze persoon net hebt opgeheven, moet u 48 uur wachten om hem/haar weer te kunnen blokkeren.
Ik vind dit commentaar
Bedankt!
Uw bericht is ter beoordeling verstuurd naar de moderatoren